Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,846 total articles
Cineverse (CNVS) is a micro-cap streaming and media-technology operator trading at roughly $2.77 with a market cap near $73M. The stock discounts its Matchpoint technology and recently aggregated FAST and SVoD assets. We see asymmetric upside if execution on ad tech and FAST monetization accelerates; trade plan: enter at $2.70, target $5.50, stop $…
Cheniere Energy has just cleared another milestone at Corpus Christi and is entering a multi-year capacity expansion cycle at a time when global LNG supply is under pressure. Fundamentals - contracted cash flows, solid free cash flow generation and visible capacity adds - make a long trade attractive over a 180-trading-day horizon with asymmetric u…
Southern Company ($SO) looks attractively positioned after a steady quarter, a supportive federal nuclear program, and a yield north of 3%. We upgrade to a buy and lay out an actionable trade with entry at $91.00, stop at $86.00, and a target of $100.84 over the next 180 trading days.
Seaport Therapeutics (SPTX) is a clinical-stage neuropsychiatry company trading at roughly $1.4B market cap with a tight float, high short interest and bullish technical momentum. The stock offers development-arbitrage upside if clinical/program milestones or partnership chatter re-rate the valuation; the trade is actionable with a mid-term horizon…
Marvell's sell-off has carved out a tactical buying opportunity. Strong AI-driven demand, healthy free cash flow and a clean balance sheet argue for a mid-term long. This trade plan gives a clear entry ($205.00), stop ($195.00) and target ($260.00) with a 45-trading-day horizon to let AI revenue momentum and technical mean reversion work in your fa…
Pfizer is an income-oriented pharma with a deep late-stage pipeline in obesity and oncology. The stock yields near 6.9%, trades around $26.60 and offers an asymmetric reward if late-stage assets like berobenatide and oncology candidates succeed. We lay out an actionable long trade with entry, stop and target and explain the catalysts, valuation con…
Repsol’s ADR is an actionable long with a clear entry, stop and target. European refining capacity remains tight, supporting margins for companies with integrated refineries. At the same time, Repsol’s push into renewable fuels (notably the Ecoplanta waste-to-methanol contract) gives the stock optionality in the energy transition. Technicals show a…
Wendy's recent management change and a trimmed payout create the cash-flow and governance backdrop for a turnaround. At roughly $1.44B market cap and trading near $7.55, the stock is attractively valued on traditional metrics; this trade targets a mid-term rerating as execution and catalysts play out.
Extreme Networks is trading well below its recent highs after a margin-driven pullback. The selloff discounts a platform transition toward cloud-native, software-defined networking and AI-enabled management. With $105M of free cash flow, a $3.12B market cap and double-digit revenue growth last year, this is a tactical long for investors willing to …
Ferrari trades at a premium, but recent Q2 strength, a raised 2026 guide, aggressive buybacks and the most complete product lineup in decades justify owning the stock. This trade idea lays out an actionable long with entry, stop and target for a long-term holding (180 trading days), explains the fundamental drivers and balances the bull case with c…
Lyft is not the global behemoth Uber is, but it has carved an economically viable niche in North America. With free cash flow of roughly $1.12B, a market cap near $7.0B and a P/E around 2.3, Lyft looks attractively priced for a mid-term tactical long. Trade plan: enter $17.55, stop $15.00, target $22.00 over a mid term (45 trading days).
Kodiak Gas Services (KGS) combines fixed-revenue contract compression with expanding distributed power opportunities tied to AI and edge power demand. The company trades at about $61.05 with a $6.54B market cap, EV/EBITDA of ~12.9 and annual free cash flow of roughly $200M. We outline a long trade with clear entry, stop and target, plus the catalys…
Meta Platforms ($META) looks oversold relative to its fundamentals. The company generates roughly $41B in free cash flow, sports a 26% return on equity, and trades at ~22x earnings - not nosebleed for a company executing AI and ad monetization plays. This trade targets a mean-reversion and sentiment rebound into AI spending updates and ad cadence o…
Guardant Health is the leading pure-play liquid biopsy name. Recent FDA expansion for Guardant360 Liquid CDx, strong technicals, and large market projections for cancer biomarkers create a clear growth narrative. This trade idea outlines a long position with precise entry, stop and target, while laying out catalysts, valuation context and risks tie…
Nvidia's latest large acquisition meaningfully expands its addressable AI stack and strengthens its moat in data-center AI. We upgrade to a constructive rating and offer a long trade designed to capture post-deal integration upside while managing valuation risk.
UnitedHealth's post-2025 profit recovery looks sustainable as medical care ratios normalize and Optum tailwinds resume. The company trades below prior highs with solid free cash flow and dividend support. This trade idea lays out an entry at $405.00, a $460.00 target and an $388.00 stop for a long-term trade (180 trading days).
Rackspace is generating positive free cash flow today and trades at an attractive price-to-sales multiple. The stock has been punished this year on restructuring and disclosure noise, but the base business - particularly Private Cloud margins and a capital-light Public Cloud services model - still turns cash. If the company can monetize enterprise …
Intuitive Machines (LUNR) is trading near $16.28 after a string of favorable NASA awards and a $1.1 billion backlog. The company remains unprofitable but has record quarterly revenue and an attractive risk-reward for a tactical long with a 180 trading day horizon. This trade plan lays out entry at $16.20, stop at $13.50 and a $25 target tied to con…
BridgeBio (BBIO) just delivered more than clinical validation with Attruby's meaningful mortality benefit and continues to de-risk multiple near-term commercial events. With a strengthened balance sheet from a $1B preferred equity raise and positive Phase 3 data for BBP-418, the risk/reward tilts toward a long trade over the next 180 trading days. …
Ceres Power (CPWHF) trades at $5.90 with improving short-term technicals, massive short interest and very low public float liquidity — a setup that offers asymmetric upside if commercialization and partner rollouts continue. This trade idea is a long with a defined entry at $5.90, stop at $4.50 and target at $12.00 over a 180 trading-day horizon, s…
Corning has been one of 2026's biggest beneficiaries of the AI-data-center buildout. The recent digestion after a strong run gives investors a concrete entry. We upgrade GLW to Buy and lay out entry, stop, and target levels across defined horizons while flagging valuation and execution risks.
CVG reported accelerating revenue and margin improvement in Q2 2026 and has meaningful upside if it delivers on raised full-year guidance. The balance sheet refinancing completed in 2025 reduces near-term liquidity risk and leaves room for operational leverage to drive EPS and free cash flow improvement. This trade plan is a long with a $3.20 entry…
TTD is trading like a fallen growth name despite solid cash generation and a deeply oversold technical picture. This trade targets a mid-term rebound into valuation normalization while respecting an elevated execution risk backdrop tied to guidance and ad market headwinds.
Meta's stock at $606 offers a way to own a large-cap ad-business cash machine with meaningful embedded upside from AI investments and partnerships. Valuation is not absurd — P/E ~22 and FCF of $40.98B — and near-term headwinds look priced in. This trade targets upside as AI monetization accelerates and infrastructure investments begin to compound.
Rakuten (RKUNY) pulled back after an operating-profit miss, but underlying growth drivers - mobile rollout, fintech monetization, and strategic satellite and payments partnerships - justify a mid-term long trade. Technicals show constructive momentum; set a disciplined stop and a realistic target near the 52-week high.
